wobenzyme

Botanicalexperimental

Clinical trial activity

7 trials · 12 clinical orgs · 0 marketing orgs

Phase 1
2
Phase 2
1
Phase 3
1
Phase 4
1

Earliest trial started Nov 2, 1999 (NCT00002311)

Timeline

1990s

  1. Jan 1, 1999

    Earliest Phase 1 Sponsor(trial)

2000s

  1. Jan 1, 2000

    Earliest Phase 2 Sponsor(trial)

Indications

Approved for

Mechanism of action

  • Unspecified targetUnclear

    unclear

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • wobenzyme

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT05038410N/AApr 30, 2021Artialis, CHR Citadelle, Free University of Brussels, Mucos Pharma GmbH and Co, Nestle, Université catholique de Louvain, University of Antwerp
NCT01916408Phase 1Aug 1, 2013Technical University of Munich
NCT01848808N/AApr 1, 2013Atrium Innovations, Laval University
NCT01845558Phase 4Feb 1, 2013Mucos Pharma GmbH and Co, PWC GmbH
NCT00974428Phase 2/Phase 3 (Phase 3)Oct 1, 2009Atrium Innovations, Centre de Rhymatologie St-Louis
NCT02088411Phase 2Nov 1, 2000Atrium Innovations, Mucos Pharma GmbH and Co
NCT00002311Phase 1Nov 2, 1999Mucos Pharma GmbH and Co
Showing 7 of 7 trials
Page 1 / 1

Organizations

Research & Development (12)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Mucos Pharma GmbH and CoFor profit4341999
Atrium InnovationsFor profit3232000
ArtialisAcademic/Hospital1012021
Centre de Rhymatologie St-LouisAcademic/Hospital1012009
CHR CitadelleAcademic/Hospital1012021
Free University of BrusselsAcademic/Hospital1012021
Laval UniversityAcademic/Hospital1112013
NestleFor profit1012021
PWC GmbHFor profit1012013
Technical University of MunichAcademic/Hospital1112013
Université catholique de LouvainAcademic/Hospital1012021
University of AntwerpAcademic/Hospital1012021
12 organizations
Page 1 / 1